This 5 years of research explores how external reference pricing (ERP, or also called as IRP – International Reference Pricing) is used to set pharmaceutical prices to improve affordability, but how its application may have negative consequences on patient access across certain countries.
Parity and time reversal elucidate both decision-making in empirical models and attractor scaling in critical Boolean networks – featured on the top journal Science Advances
New Publication Co-Authored by Dávid Deritei Read More »
Akceso Advisors AG
Aeschengraben 29.
CH-4051 Basel, Switzerland
Verity IRP Master Tool
Verity Analogues Wizard
Verity Prices & Reimbursements
Verity MarketScout Rules & Regulations
Verity Managed Entry Agreements
Verity Tender Management
Verity Approvals
PRiMA Headlines
© 2011-2024 Akceso Advisors AG | Photos by Luca Gőbölyös & Thomas Bittera
Get in touch with us and schedule a demo.
Error: Contact form not found.
The PRiMA Headlines Newsletter provides a monthly overview of developments in Pricing, Reimbursement and Market Access across the globe. Since its launch in June 2015 we have covered more than 8,000 stories from over 160 countries.
